C4 Therapeutics, Inc. (CCCC) Net margin 2021–2025
C4 Therapeutics, Inc. (CCCC) net profit margin by fiscal year — reported net income divided by reported revenue.
-292.1%FY2025 · since FY2021: -183.2% → -292.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -292.1% | +3.9 pp |
| FY2024 | -296.0% | +342.4 pp |
| FY2023 | -638.3% | -226.1 pp |
| FY2022 | -412.2% | -229.0 pp |
| FY2021 | -183.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice